MARIALISON BOWLING: Open Payments
NPI 1952765174 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 24 payments from 8 companies in 2025. Trend: 2023 $786 · 2024 $359 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $197 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
| Corium, LLC | 1 | $15 |
Products named: VRAYLAR, Jornay PM, REXULTI, INVEGA SUSTENNA, Qelbree, TRINTELLIX, Azstarys.
Industry payments across AR — which companies pay providers there.
